期刊
NEUROPSYCHOPHARMACOLOGY
卷 32, 期 1, 页码 180-189出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.npp.1301153
关键词
dopamine; accumbens; learning; Parkinson's disease; fMRI; cognition
资金
- Medical Research Council [G0300723B, G0001354B] Funding Source: researchfish
- Medical Research Council [G0001354] Funding Source: Medline
- Wellcome Trust [076274/4/Z/04/Z] Funding Source: Medline
Evidence indicates that dopaminergic medication in Parkinson's disease may impair certain aspects of cognitive function, such as reversal learning. We used functional magnetic resonance imaging in patients with mild Parkinson's disease to investigate the neural site at which L-DOPA acts during reversal learning. Patients were scanned both ON and OFF their normal dopamine-enhancing L-DOPA medication during the performance of a probabilistic reversal learning task. We demonstrate that L-DOPA modulated reversal-related activity in the nucleus accumbens, but not in the dorsal striatum or the prefrontal cortex. These data concur with evidence from studies with experimental animals and indicate an important role for the human nucleus accumbens in the dopaminergic modulation of reversal learning.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据